In adenomyotic lesions found the presence of GnRH receptors, the use of GnRH agonists in the treatment process is considered to have antiproliferative, hypoestrogenic effects, reduce angiogenesis and inflammatory reactions that will induce apoptosis in cases of adenomyosis [14]. The gene discussed is GNRH1; the disease is adenomyosis.